This presentation will focus on the assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy, and is based on a 2018 position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.